Merck (NYSE:MRK) announced Tuesday that the European Commission approved its anti-cancer agent Welireg (belzutifan) as a ...

Ocular biomarkers for anemia in diabetic kidney disease include disruption of the external limiting membrane and ellipsoid zone.

Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...

There are currently 82,000 incident cases of RCC annually in the United States (account for 3–5% of cancers), with 15,000 deaths annually in the United States. The overall 5-year mortality risk is ~30 ...

What is a kidney scan? A kidney scan is an imaging test that looks at your kidneys. Your health care provider can also see how well blood is flowing in your kidneys. A kidney scan is also called a ...

Therefore, we implemented, regardless of malignancy, a doppler ultrasound of the renal graft to be obtained immediately after surgery and repeated every 6 months for 2 years followed by a CT scan of ...

We provide data on prevalence, risk factors and consequences of acute kidney injury (AKI), which are scarce in sub-Saharan Africa (SSA). We make use of the expanding availability of point of care ...

Diagnostic ultrasound is a valuable modality and is not contraindi-cated where medical benefit is expected. Furthermore, there are no confirmed biological effects on patients caused by exposures from ...

Amelia Ti is a Registered Dietitian (RD) and Certified Diabetes Care and Education Specialist (CDCES) based in NYC. She completed her Bachelor's in Nutrition & Dietetics at NYU and Master's in ...

High blood sugar levels not only impair the metabolic condition but also affect our kidney health. Diabetes is one of the leading causes of kidney diseases across the globe as improper blood sugar ...

A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in people who also had diabetes. It also reduced the ...

By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.